The Europe an Medicines Agency regulatory committee announced the results of its review on Friday. It’s the latest group to conclude there’s no known tie between a new class of obesity drugs and suicide.
A federally funded U.S. study also found that people taking semaglutide, the medication in Ozempic and Wegovy, had a lower risk of suicidal thoughts than those taking older medications to treat diabetes and obesity.
Drug Regulators Europe Diabetes Drugs Weight-Loss Drugs Ozempic Wegovy Suicidal Thoughts Actions European Medicines Agency Review Obesity Drugs Tie U.S. Food And Drug Administration Small Risk Federally Funded U.S. Study Semaglutide Lower Risk Self-Harm
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Gold goes higher and higher - what next?The Kitco News Team brings you the latest news, videos, analysis and opinions regarding Precious Metals, Crypto, Mining, World Markets and Global Economy.
Source: KitcoNewsNOW - 🏆 13. / 78 Read more »
Intermittent Fasting Associated With Higher Risk Of Dying From Heart Disease, New Study SaysThose who restricted themselves to the eating schedule in question had a 91% higher risk of death from cardiovascular disease, the researchers found.
Source: boredpanda - 🏆 18. / 72 Read more »
EU Probe Finds No Added Suicide Risk Linked to Novo’s WegovyThe European Union’s drug regulator found no added risk of suicide or self-harm for people taking a popular new class of weight-loss and diabetes medicines that includes Novo Nordisk A/S’s Wegovy and Ozempic.
Source: BNNBloomberg - 🏆 83. / 50 Read more »
Severe COVID leads to higher risk of pulmonary fibrosis: researchDoctor Daniel Marinescu, a respirologist, describes a patient's CT scan. He points out scarring on the lungs of the patient which can occur after long COVID.
Source: CBC - 🏆 32. / 63 Read more »
Apple faces 'headline risk' from regulators, not fundamental riskApple (AAPL) faces regulatory pressures after reports of several investigations, from an antitrust lawsuit brought on by the US Department of Justice (DOJ...
Source: YahooFinanceCA - 🏆 47. / 63 Read more »
No link between Ozempic, Wegovy and suicide, EU drug regulators sayDrug regulators in Europe have found no evidence that popular diabetes and weight-loss drugs like Ozempic and Wegovy are linked to a higher risk of suicidal ...
Source: YahooFinanceCA - 🏆 47. / 63 Read more »